...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AGM - High Level Summary
7
Jan 07, 2016 03:54PM
2
Jan 07, 2016 03:58PM
4
Jan 07, 2016 06:25PM
4
Jan 07, 2016 06:59PM
2
Jan 07, 2016 07:35PM
7
Jan 07, 2016 11:57PM
3
Jan 08, 2016 12:06AM
4
Jan 08, 2016 07:18AM
2
Jan 08, 2016 01:40PM
2
Jan 08, 2016 03:07PM
1
Jan 12, 2016 10:30AM
3
Jan 12, 2016 05:38PM

Toinv that is correct, Don said that after Brad Cann has done his accounting wizardry that all shareholders of ZCC would have the same number of shares in the new operating company.

I assume you don't mean Zenith Epigenetics Ltd (Newco). It will have only 34.4 million shares total.


Jan 12, 2016 06:48PM
5
Jan 12, 2016 08:25PM
1
Jan 12, 2016 08:50PM
5
Jan 12, 2016 10:14PM
3
Jan 12, 2016 11:04PM
4
Jan 13, 2016 08:58AM
5
Jan 13, 2016 01:37PM
1
Jan 13, 2016 02:01PM
Share
New Message
Please login to post a reply